ProCE Banner Activity

Renal Cell Carcinoma: Evolving Perspectives on Optimal Treatment

Slideset

Download this slideset for expert perspectives and key data on contemporary treatment for patients with nonmetastatic and advanced RCC. 

Released: August 19, 2024

Expiration: August 18, 2025

Share

Faculty

Katy Beckermann

Katy Beckermann, MD, PhD

Assistant Professor of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

Eric Jonasch

Eric Jonasch, MD

Professor, Department of GU Medical Oncology
UT MD Anderson Cancer Center 
Houston, Texas

Provided by

Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by educational grants from AVEO Pharmaceuticals, Inc. (“AVEO Oncology, an LG Chem company”) and Eisai. This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

AVEO Pharmaceuticals, Inc.

Eisai

Merck & Co., Inc.

Partners

Clinical Care Options, LLC

ProCE Banner